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Introduction
Alternative splicing events (ASEs) are present in almost all multi-
exonic human genes1,2 and are believed to be one of the most 
significant components behind the complexity of multi-cellular 
organisms.1,3,4 Furthermore, ASEs are clearly involved in the eti-
ology of a wide variety of diseases, including cancer,5-7 ischemia8 
and other common human disorders.9 Recently, several studies 
have shown that constitutive and alternative splicing are regu-
lated by a complex network of cellular elements, which include a 
set of trans-acting factors and cis-acting sequences found in the 
primary RNAs.10-18
The complex regulation of splicing and the high frequency 
of ASEs explain the appearance of Complex Alternative Splicing 
Events (CASEs), which are composed by a regulated combina-
tion of two or more single ASEs in transcripts from the same 
gene, or even in the same transcript. The most striking example 
of CASE is the Dscam in Drosophila, a gene containing a cluster 
of 48 mutually exclusive exons that, in principle, can generate 
thousands of splicing variants.19
Understanding alternative splicing is crucial to elucidate the mechanisms behind several biological phenomena, including 
diseases. The huge amount of expressed sequences available nowadays represents an opportunity and a challenge to 
catalog and display alternative splicing events (ASes). Although several groups have faced this challenge with relative 
success, we still lack a computational tool that uses a simple and straightforward method to retrieve, name and present 
ASes. here we present SPLOOce, a portal for the analysis of human splicing variants. SPLOOce uses a method based on 
regular expressions for retrieval of ASes. We propose a simple syntax that is able to capture the complexity of ASes.
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In humans, some ASEs and CASEs occurring in oncogenes 
and tumor suppressor genes have already been associated to can-
cer.6,20-23 For example, the gene NTRK1 (nerve growth factor) 
has a sequence variant, TrkAIII, which is common in certain 
tumors and lacks three exons that affect a regulatory immu-
noglobulin-like domain.24 Further CASE examples include the 
gene CD44, which is a known marker of malignancy and inva-
siveness and has about ten ASEs that can occur in different com-
binations in its region coding for the extra-cellular portion of the 
protein.20,21,23
In spite of the efforts of other groups,25-27 a simple and efficient 
nomenclature to take into account all the variability generated by 
alternative splicing, especially for CASEs, is still missing. Here, 
we present a web portal, SPLOOCE, which uses a method based 
on regular expressions with an associated syntax. SPLOOCE 
provides a series of tools that allow users to profile splicing vari-
ants and analyze their functional impacts.
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using Pfam data and HMMER 3.0 program.34 All these data are 
shown graphically (Fig. 2C).
Analysis. To illustrate the use of SPLOOCE, some basic 
questions about the frequency and mode of alternative splicing 
events were addressed. Table 1 shows the frequency of all types 
of ASEs in our data set. As expected, exon skipping (ES) is the 
most frequent type of alternative splicing. One interesting aspect 
that our method allowed us to explore is the distribution of dual-
specific splicing (DSS) events. This type of event was found in 
53 (0.27%) human genes (Table S2). In a less restrictive analy-
sis, without considering the number of supporting sequences, the 
number of genes showing this type of event increased to 577. 
DSSs events were found to occur frequently in genes such as 
DIABLO, IRF3 and MAG, and they can occur together with 
other events as shown in Table 2.
Another interesting feature that our method allows us to evalu-
ate is the combination of events occurring in the same mRNA mol-
ecule. Each pair-wise comparative sequence in our pipeline contains 
on average 1.6 events and 46.87% and 12.21% of these pairwise 
comparisons report more than one or two events, respectively.
To better understand what influences the frequency of ASEs 
and CASEs, some patterns were further explored. For example, 
the combination of two adjacent ES events is significantly more 
frequent among all sets of CASEs (Table 3). This excess is absent 
in situations when both events are not adjacent, like in the pat-
terns –s-E-s- and –s-E-E-s- . Do these adjacent events tend to 
maintain the phase of an ORF? When adjacent, 60.78% of -E-E-
s-s-E-E- maintains the ORF. This is significantly higher than 
what one would expect by chance based on all pairs of exons 
in the human genome that maintain an ORF (p < 0.001). This 
strongly suggests that adjacent ES events are under selection to 
maintain the ORF. The same pattern is not observed for other 
types of CASEs (data not shown).
Material and Methods
Public data. The human genome reference sequence (NCBI36/
hg18) was downloaded from UCSC Genome Bioinformatics 
Results and Discussion
For the sake of space and clarity, we opted to describe the method 
used in this report as supplemental material, although an over-
view is present in Figure 1. In this section we present an imple-
mentation of the method in a computational tool, SPLOOCE 
and illustrate the use of SPLOOCE discussing a few examples.
Implementation. To make the method described in the sup-
plemental material available to the community in an easy way, 
a web tool called SPLOOCE was implemented. SPLOOCE is 
available at http://www.bioinformatics-brazil.org/splooce. Data 
sources include RefSeqs, mRNAs, ESTs and data from NGS.
To help the users, SPLOOCE provides in the query box a quick 
reference table explaining the syntax and showing some illustra-
tive examples. All ASEs and CASEs identified by SPLOOCE can 
also be displayed for a specific gene by simply typing the gene 
name between quotes in the query box (Fig. 2). SPLOOCE also 
provides advanced options for querying. Filters for chromosome, 
strand, gene name and sequence type are provided. Users can also 
evaluate the specificity of ASEs and CASEs expression regarding 
both tissue and pathology. A score for expression specificity is 
provided, which is a simple Χ2 distribution analysis done among 
the expressed sequences supporting the corresponding variant. 
The analysis is based on the annotation provided by eVOC33 for 
ESTs and manual curation for NGS sequences.
Results provided by SPLOOCE can be downloaded in a GFF 
file format. By default, results are shown in a table containing 
chromosome, genomic position, gene name and a pictorial view 
of the respective ASE or CASE, followed by the amount of their 
respective supporting sequences. SPLOOCE also provides a link 
to the UCSC Genome Browser (with tracks), and a local link for 
additional information.
When a Reference Sequence (RefSeq) is involved in an ASE, 
it is used as a template for creating a new mRNA sequence con-
taining the specified event. For each of these new sequences, 
SPLOOCE predicts its open reading frame (ORF), which is then 
translated to a protein. Moreover, aiming to infer additional bio-
logical significance, SPLOOCE analyzes the protein domains 
Figure 1. General strategy to process and analyze cASes in a set of expressed sequences.
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Bioinformatics portal (file mrna.fa, for Homo sapiens). ESTs 
sequences were downloaded from dbEST (http://www.ncbi.nlm.
nih.gov/dbEST/). RNA-seq reads were downloaded from SRA 
database (http://www.ncbi.nlm.nih.gov/sra; IDs: SRX003935, 
portal (http://genome.ucsc.edu). RefSeq sequences were down-
loaded from the Reference Sequence database (release 25; 
http://www.ncbi.nlm.nih.gov/RefSeq/). A total of 203,649 
mRNAs sequences were downloaded from UCSC Genome 
Figure 2. (A) SPLOOce query form also showing a tab for advanced parameters. (B) example of the table of results for a query. (c) Some results that 
can be found in the section “Details” provided by SPLOOce. in this example, a double skipping (syntax: -e-s-s-e-) that codifies a protein domain is 
shown.
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(splice junctions) with a RefSeq sequence were merged together. 
Third, the remaining non-RefSeq transcripts showing only one 
exon and overlapping greater than 30 nt with a RefSeq transcript 
were grouped together. All clustering information was stored in 
a relational database.
Alternative splicing. Analyses of ASEs and CASEs were 
done using regular expressions, as detailed in the supplemental 
material. In the analysis of ASEs, only cDNA clusters contain-
ing RefSeqs and/or mRNAs or more than 10 ESTs/RNA-seq 
were used. The redundancy of ASEs, such as exon skipping and 
intron retention, was eliminated by comparing all events of the 
same type from each gene. Afterwards, all events showing posi-
tion overlap were clustered together and counted as one event. All 
other events, such as 3'/5' alternative splice sites and dual-specific 
splice sites, were counted by verifying the position of the alterna-
tive splice site. The number of genes affected by specific CASEs 
was defined through the analysis of the full list of comparative 
matrices, not considering the number of supporting sequences.
Conclusion
Although previous methods and interfaces have been pro-
posed25-27 for the study of alternative splicing, all of them pres-
ent limitations as discussed before.27 SPLOOCE, described here, 
is an efficient and complementary alternative for the analysis of 
alternative splicing events due to its high flexibility in the query-
ing patterns and variety of applications.
Like ASTALAVISTA,27 the method used by SPLOOCE 
is based in a comparison of all transcripts for a given locus. 
SPLOOCE, however, uses a notation system based on regular 
expressions to provide a simple and straightforward syntax for 
splicing events. The design of the syntax was developed to pro-
vide a set of simple and intuitive characters, and is actually capa-
ble of representing any CASE pattern, including those that have 
rare DSS events. The proposed syntax was successfully imple-
mented and it may become a standard way for representing ASEs 
and CASEs.
Acknowledgments
Part of this work was supported by grants from the 
Fogarty International Center, National Institute of Health 
(D43TW007015 to L.O.M.); Coordenação de Aperfeiçoamento 
de Pessoal de Nível Superior (CAPES); and from Fundação 
de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 
(2007/55790–5 to S.J.S. and 2009/53853–5 to S.J.S.). Funding 
for open access charge: Fundação de Amparo à Pesquisa do 
Estado de São Paulo.
Supplemental Material
Supplemental material may be found here: 
www.landesbioscience.com/journals/rna/article/22181
SRX003934, SRX003933, SRX003932, SRX003931, 
SRX003930, SRX003929, SRX003928, SRX003927, 
SRX003926).
Sequence alignment. All RefSeqs, mRNAs and ESTs 
sequences were aligned to the human genome using the protocol 
described previously.28 In brief, first all long sequences (RefSeq, 
mRNAs and ESTs) were mapped against the human genome 
using the BLAT alignment tool29 and only the best alignment 
for each sequence was selected. Next, those transcripts showing 
alignment identity greater than 95% and a covering more than 
90% of its sequence length were remapped using SIM430 and 
stored in a relational database. RNA-seq data were mapped to 
human genome using Tophat-based pipeline,31 and all mapped 
reads were submitted to Cufflinks.32 Default parameters were 
used in both algorithms.
Sequence clustering. All mapped sequences sharing the same 
genomic region were grouped together using a gene-oriented strat-
egy as described previously.4,28 First, all RefSeq sequences were 
annotated based on the corresponding “official gene name” from 
NCBI-Gene (http://www.ncbi.nlm.nih.gov/gene/). Second, all 
non-RefSeq transcripts (mRNAs, ESTs and RNA-seq) presenting 
multiple exons and sharing one or more exon-intron boundaries 
Table 1. Frequency of the major types of ASes
Simple alternative 
splicing event
Genes
Total 
Events
Events 
per Gene
exon skipping 10125 (51,77%) 38060 1,95
Alternative 3' splice site 7490 (38,30%) 30172 1,54
Alternative 5' splice site 7258 (37,11%) 27585 1,41
intron retention 6565 (33,57%) 12632 0,65
Dual-specific splice site 53 (0,27%) 112 0,0057
Table 2. Frequency of DSS events coupled to other types of ASes
Syntax Frequency (Genes) Pattern (Simple)
d 577 (2.95%) 23 or 32
-d- 181 (0.93%) 0230 or 0320
-d-s- 85 (0.43%) 023030 or 032020
-ed- 57 (0.29%) 01230 or 01320
-d-T 57 (0.29%) 023031 or 032021
-de- 56 (0.28%) 02310 or 03210
f-d-T 26 (0.13%) 12023031 or 13032021
e-d-T 20 (0.10%) 1023031 or 1032021
-ede- 17 (0.087%) 012310 or 013210
-d-t 11 (0.06%) 023021 or 032031
-d-S- 8 (0.04%) 023020 or 032030
-df- 5 (0.025%) 023120 or 032130
-tD- 3 (0.015%) 021320 or 031230
f-D-T 2 (0.01%) 12032021 or 13023031
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